Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK1 | P04183 | 1/20 | 0.52 |
| ▸ | HPRT1 | P00492 | 8/20 | 0.49 |
| ▸ | PNP | P00491 | 7/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7567195 | 0.94 | HPRT1 (0.51) | TK1HPRT1PNP | |
| SCHEMBL7397889 | 0.86 | MAPK1 (0.49) | HPRT1PNPCYP3A4MAPK1 | |
| SCHEMBL7576803 | 0.84 | TK1 (0.60) | TK1HPRT1PNP | |
| SCHEMBL7570970 | 0.83 | TK1 (0.51) | TK1HPRT1PNP | |
| SCHEMBL7575116 | 0.82 | TK1 (0.59) | TK1HPRT1PNP | |
| SCHEMBL7570078 | 0.82 | TK1 (0.65) | TK1HPRT1PNPCYP3A4 | |
| SCHEMBL7980712 | 0.80 | TK1 (0.53) | TK1HPRT1PNP | |
| SCHEMBL7982329 | 0.80 | TK1 (0.57) | TK1HPRT1PNP | |
| SCHEMBL7572302 | 0.80 | TK1 (0.48) | TK1HPRT1PNP | |
| SCHEMBL7396839 | 0.80 | HPRT1 (0.48) | HPRT1PNPMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1237890-A1 | SYNTHESIS AND METHODS OF USE OF 9-SUBSTITUTED GUANINE DERIVATIVES | Neotherapeutics, Inc. (US) | 2002-09-11 | — | — | EP | claimed |
| US-6297226-B1 | TREATING A DISEASE OR A CONDITION IN A MAMMAL TREATABLE BY INHIBITING THE ACTIVITY OF A MONOAMINE OXIDASE | NEOTHERAPEUTICS, INC. | 2001-10-02 | — | — | US | claimed |
| WO-2001029039-A1 | SYNTHESIS AND METHODS OF USE OF 9-SUBSTITUTED GUANINE DERIVATIVES | NEOTHERAPEUTICS, INC. (US) | 2001-04-26 | — | — | WO | claimed |
| EP-1237890-A1 | SYNTHESIS AND METHODS OF USE OF 9-SUBSTITUTED GUANINE DERIVATIVES | Neotherapeutics, Inc. (US) | 2002-09-11 | — | — | EP | disclosed |
| US-6297226-B1 | TREATING A DISEASE OR A CONDITION IN A MAMMAL TREATABLE BY INHIBITING THE ACTIVITY OF A MONOAMINE OXIDASE | NEOTHERAPEUTICS, INC. | 2001-10-02 | — | — | US | disclosed |
| WO-2001029039-A1 | SYNTHESIS AND METHODS OF USE OF 9-SUBSTITUTED GUANINE DERIVATIVES | NEOTHERAPEUTICS, INC. (US) | 2001-04-26 | — | — | WO | disclosed |